Literature DB >> 27930794

Using Donor Lenticules Obtained Through SMILE for an Epikeratophakia Technique Combined With Phototherapeutic Keratectomy.

Jing Zhao, Ling Sun, Yang Shen, Mi Tian, Peijun Yao, Xingtao Zhou.   

Abstract

PURPOSE: To investigate the feasibility, safety, and efficacy of using a donor lenticule created during small incision lenticule extraction (SMILE) in an epikeratophakia technique combined with phototherapeutic keratectomy (PTK).
METHODS: Six patients with decreased visual acuity due to a recurrence of corneal dystrophy were included in this prospective pilot study. PTK was performed using the MEL 80 excimer laser (Carl Zeiss Meditec, Jena, Germany) followed by the transplantation of donor lenticules onto the recipient eyes. These lenticules were extracted during SMILE procedures using the VisuMax femtosecond laser (Carl Zeiss Meditec) on 6 donors with myopia and served as the epikeratophakia tissue.
RESULTS: The surgeries and postoperative follow-up examinations were uneventful and no complications were noted over 6 months of follow-up. The epithelium remodelling was achieved within 1 month. At the last measurement, the corrected distance visual acuity of all recipient eyes gained at least two lines. Five eyes (83.3%) gained at least two lines of uncorrected distance visual acuity compared to their preoperative levels. Mean keratometric power increased by 5.97 ± 3.73 diopters and central corneal thickness increased by 55.25 ± 36.38 µm. The epithelium healed and the lenticules remained clear over the follow-up period as observed under slit-lamp examination. Anterior segment optical coherence tomography observation showed the lenticule was transparent with a visible demarcation line during the follow-up examination.
CONCLUSIONS: The use of a SMILE lenticule as a donor lenticule for an epikeratophakia technique appears feasible and safe in the short term. The predictability and long-term effects need further investigation. [J Refract Surg. 2016;32(12):840-845.]. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Year:  2016        PMID: 27930794     DOI: 10.3928/1081597X-20160920-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  6 in total

1.  Effect of corneal stromal lenticule customization on neurite distribution and excitatory property.

Authors:  Gary Hin-Fai Yam; Francisco Bandeira; Yu-Chi Liu; Kavya Devarajan; Nur Zahirah Binte M Yusoff; Hla-Myint Htoon; Jodhbir S Mehta
Journal:  J Adv Res       Date:  2021-09-16       Impact factor: 12.822

Review 2.  A novel case using femtosecond laser-acquired lenticule for recurrent pterygium: case report and literature review.

Authors:  Om Prakash Pant; Ji-Long Hao; Dan-Dan Zhou; Fan Wang; Cheng-Wei Lu
Journal:  J Int Med Res       Date:  2018-04-16       Impact factor: 1.671

3.  Two-year outcome of an eye that underwent hyperopic LASIK following inadvertent myopic SMILE lenticule in situ implantation.

Authors:  Jing Zhao; Jianmin Shang; Lingling Niu; Haipeng Xu; Dong Yang; Yu Zhao; Dan Fu; Xingtao Zhou
Journal:  BMC Ophthalmol       Date:  2019-08-08       Impact factor: 2.209

4.  Multiple phototherapeutic keratectomy treatments in a Chinese pedigree with corneal dystrophy and an R124L mutation: a 20-year observational study.

Authors:  Li Zeng; Jing Zhao; Yingjun Chen; Jianmin Shang; Aruma Aruma; Xingtao Zhou
Journal:  BMC Ophthalmol       Date:  2019-08-22       Impact factor: 2.209

5.  Femtosecond Laser-Assisted Small Incision Allogeneic Endokeratophakia Using a Hyperopic Lenticule in Rabbits.

Authors:  Tian Han; Yang Shen; Jianmin Shang; Dan Fu; Feng Zhao; Jing Zhao; Meiyan Li; Xingtao Zhou
Journal:  Transl Vis Sci Technol       Date:  2021-10-04       Impact factor: 3.283

Review 6.  Lamellar keratoplasty using femtosecond laser intrastromal lenticule for limbal dermoid: case report and literature review.

Authors:  Om Prakash Pant; Ji-Long Hao; Dan-Dan Zhou; Fan Wang; Bing-Jie Zhang; Cheng-Wei Lu
Journal:  J Int Med Res       Date:  2018-08-08       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.